Potassium channel Kv2.1 regulates potassium current in cortical neurons and potassium efflux is necessary for cell apoptosis. As a major component of delayed rectifier current potassium channels, Kv2.1 forms clusters in the membrane of hippocampal neurons. BACE2 is an aspartyl protease to cleave APP to prevent the generation of Aβ, a central component of neuritic plaques in Alzheimer’s brain. We now identified Kv2.1 as a novel substrate of BACE2. We found that BACE2 cleaved Kv2.1 at Thr376, Ala717, and Ser769 sites and disrupted Kv2.1 clustering on cell membrane, resulting in decreased Ik of Kv2.1 and a hyperpolarizing shift in primary neurons. Furthermore, we discovered that the BACE2-cleaved Kv2.1 forms, Kv2.1-1-375, Kv2.1-1-716, and Kv2.1-1-768, depressed the delayed rectifier Ik surge and reduced neuronal apoptosis. Our study suggests that BACE2 plays a neuroprotective role by cleavage of Kv2.1 to prevent the outward potassium currents, a potential new target for Alzheimer’s treatment.
Subscribe to Journal
Get full journal access for 1 year
only $62.92 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Pongs O. Structural basis of potassium channel diversity in the nervous system. J Basic Clin Physiol Pharmacol. 1990;1:31–9.
Murakoshi H, Trimmer JS. Identification of the Kv2.1 K+ channel as a major component of the delayed rectifier K+ current in rat hippocampal neurons. J Neurosci. 1999;19:1728–35.
Long SB, Campbell EB, Mackinnon R. Crystal structure of a mammalian voltage-dependent Shaker family K+ channel. Science. 2005;309:897–903.
Papazian DM. Potassium channels: some assembly required. Neuron. 1999;23:7–10.
Pal S, Hartnett KA, Nerbonne JM, Levitan ES, Aizenman E. Mediation of neuronal apoptosis by Kv2.1-encoded potassium channels. J Neurosci. 2003;23:4798–802.
Redman PT, He K, Hartnett KA, Jefferson BS, Hu L, Rosenberg PA, et al. Apoptotic surge of potassium currents is mediated by p38 phosphorylation of Kv2.1. Proc Natl Acad Sci USA. 2007;104:3568–73.
Yao H, Zhou K, Yan D, Li M, Wang Y. The Kv2.1 channels mediate neuronal apoptosis induced by excitotoxicity. J Neurochem. 2009;108:909–19.
Nakagawa T, Zhu H, Morishima N, Li E, Xu J, Yankner BA, et al. Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta. Nature. 2000;403:98–103.
Yan R, Vassar R. Targeting the beta secretase BACE1 for Alzheimer’s disease therapy. Lancet Neurol. 2014;13:319–29.
Sun X, Bromley-Brits K, Song W. Regulation of beta-site APP-cleaving enzyme 1 gene expression and its role in Alzheimer’s disease. J Neurochem. 2012;120:62–70.
Ly PT, Wu Y, Zou H, Wang R, Zhou W, Kinoshita A, et al. Inhibition of GSK3β-mediated BACE1 expression reduces Alzheimer-associated phenotypes. J Clin Invest. 2013;123:224–35.
Zhang S, Wang Z, Cai F, Zhang M, Wu Y, Zhang J, et al. BACE1 cleavage site selection critical for amyloidogenesis and Alzheimer’s pathogenesis. J Neurosci. 2017;37:6915–25.
Sun X, Tong Y, Qing H, Chen CH, Song W. Increased BACE1 maturation contributes to the pathogenesis of Alzheimer’s disease in Down syndrome. FASEB J. 2006;20:1361–8.
Acquati F, Accarino M, Nucci C, Fumagalli P, Jovine L, Ottolenghi S, et al. The gene encoding DRAP (BACE2), a glycosylated transmembrane protein of the aspartic protease family, maps to the down critical region. FEBS Lett. 2000;468:59–64.
Sun X, He G, Song W. BACE2, as a novel APP theta-secretase, is not responsible for the pathogenesis of Alzheimer’s disease in Down syndrome. FASEB J. 2006;20:1369–76.
Liu X, Wang Z, Wu Y, Wang J, Song W. BACE2 degradation mediated by the macroautophagy-lysosome pathway. Eur J Neurosci. 2013;37:1970–7.
Brown AM. The pore of voltage-dependent potassium channels. Ren Physiol Biochem. 1994;17:178–81.
Brown AM, Drewe JA, Hartmann HA, Taglialatela M, De Biasi M, Soman K, et al. The potassium pore and its regulation. Ann NY Acad Sci. 1993;707:74–80.
Fox PD, Loftus RJ, Tamkun MM. Regulation of Kv2.1 K(+) conductance by cell surface channel density. J Neurosci. 2013;33:1259–70.
Deutsch E, Weigel AV, Akin EJ, Fox P, Hansen G, Haberkorn CJ, et al. Kv2.1 cell surface clusters are insertion platforms for ion channel delivery to the plasma membrane. Mol Biol Cell. 2012;23:2917–29.
O’Connell KM, Tamkun MM. Targeting of voltage-gated potassium channel isoforms to distinct cell surface microdomains. J Cell Sci. 2005;118(Pt 10):2155–66.
O’Connell KM, Rolig AS, Whitesell JD, Tamkun MM. Kv2.1 potassium channels are retained within dynamic cell surface microdomains that are defined by a perimeter fence. J Neurosci. 2006;26:9609–18.
Lim ST, Antonucci DE, Scannevin RH, Trimmer JS. A novel targeting signal for proximal clustering of the Kv2.1 K+ channel in hippocampal neurons. Neuron. 2000;25:385–97.
Scannevin RH, Murakoshi H, Rhodes KJ, Trimmer JS. Identification of a cytoplasmic domain important in the polarized expression and clustering of the Kv2.1 K+ channel. J Cell Biol. 1996;135(6 Pt 1):1619–32.
Mohapatra DP, Siino DF, Trimmer JS. Interdomain cytoplasmic interactions govern the intracellular trafficking, gating, and modulation of the Kv2.1 channel. J Neurosci. 2008;28:4982–94.
Immke D, Wood M, Kiss L, Korn SJ. Potassium-dependent changes in the conformation of the Kv2.1 potassium channel pore. J Gen Physiol. 1999;113:819–36.
Gonzalez C, Baez-Nieto D, Valencia I, Oyarzun I, Rojas P, Naranjo D, et al. K(+) channels: function-structural overview. Comp Physiol. 2012;2:2087–149.
Kalia J, Swartz KJ. Exploring structure-function relationships between TRP and Kv channels. Sci Rep. 2013;3:1523.
Xu H, Barry DM, Li H, Brunet S, Guo W, Nerbonne JM. Attenuation of the slow component of delayed rectification, action potential prolongation, and triggered activity in mice expressing a dominant-negative Kv2 alpha subunit. Circ Res. 1999;85:623–33.
Malin SA, Nerbonne JM. Delayed rectifier K+ currents, IK, are encoded by Kv2 alpha-subunits and regulate tonic firing in mammalian sympathetic neurons. J Neurosci. 2002;22:10094–105.
Turner RT 3rd, Koelsch G, Hong L, Castanheira P, Ermolieff J, Ghosh AK, et al. Subsite specificity of memapsin 2 (beta-secretase): implications for inhibitor design. Biochemistry. 2001;40:10001–6.
Doody RS, Thomas RG, Farlow M, Iwatsubo T, Vellas B, Joffe S, et al. Phase 3 trials of solanezumab for mild-to-moderate Alzheimer’s disease. N Engl J Med. 2014;370:311–21.
Salloway S, Sperling R, Fox NC, Blennow K, Klunk W, Raskind M, et al. Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer’s disease. N Engl J Med. 2014;370:322–33.
Park KS, Mohapatra DP, Misonou H, Trimmer JS. Graded regulation of the Kv2.1 potassium channel by variable phosphorylation. Science. 2006;313:976–9.
Nunomura A, Perry G, Aliev G, Hirai K, Takeda A, Balraj EK, et al. Oxidative damage is the earliest event in Alzheimer disease. J Neuropathol Exp Neurol. 2001;60:759–67.
Pratico D. Alzheimer’s disease and oxygen radicals: new insights. Biochem Pharmacol. 2002;63:563–7.
Selkoe DJ. Alzheimer’s disease: genes, proteins, and therapy. Physiol Rev. 2001;81:741–66.
Chen CH, Zhou W, Liu S, Deng Y, Cai F, Tone M, et al. Increased NF-kappaB signalling up-regulates BACE1 expression and its therapeutic potential in Alzheimer’s disease. Int J Neuropsychopharmacol. 2012;15:77–90.
Cotella D, Hernandez-Enriquez B, Wu X, Li R, Pan Z, Leveille J, et al. Toxic role of K+ channel oxidation in mammalian brain. J Neurosci. 2012;32:4133–44.
Bennett BD, Babu-Khan S, Loeloff R, Louis JC, Curran E, Citron M, et al. Expression analysis of BACE2 in brain and peripheral tissues. J Biol Chem. 2000;275:20647–51.
Holler CJ, Webb RL, Laux AL, Beckett TL, Niedowicz DM, Ahmed RR, et al. BACE2 expression increases in human neurodegenerative disease. Am J Pathol. 2012;180:337–50.
Sun X, He G, Qing H, Zhou W, Dobie F, Cai F, et al. Hypoxia facilitates Alzheimer’s disease pathogenesis by up-regulating BACE1 gene expression. Proc Natl Acad Sci USA. 2006;103:18727–32.
We thank Yu Tian Wang and Zhifang Dong for helpful discussions. This study was supported by the National Natural Science Foundation of China (NSFC) grant 81322014 (XS), and the Canadian Institutes of Health Research (CIHR) Operating Grant MOP-142487 (WS). WS is the holder of the Tier 1 Canada Research Chair in Alzheimer’s Disease. YZ is the recipient of Michael Smith Foundation for Health Research Post-Doctoral Fellowship Award.
XS and WS conceived and designed the experiments; FL, YZ, ZL, QS, HL, JZhao, JX, JZheng, YY, and XY performed the experiments. FL, YZ, XY, XS and WS analyzed and contributed reagents /materials /analysis tools; FL, YZ, XS and WS wrote the paper. All authors reviewed the manuscript.
Conflict of interest
The authors declare that they have no conflict of interest.
These authors contributed equally: Fuchen Liu, Yun Zhang.
Electronic supplementary material
About this article
Cite this article
Liu, F., Zhang, Y., Liang, Z. et al. Cleavage of potassium channel Kv2.1 by BACE2 reduces neuronal apoptosis. Mol Psychiatry 23, 1542–1554 (2018). https://doi.org/10.1038/s41380-018-0060-2
BMC Molecular and Cell Biology (2020)
BioMed Research International (2020)
Molecular Psychiatry (2019)
New England Journal of Medicine (2019)